Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Should hypogonadal men who are suboptimally responsive to testosterone gel switch to another gel preparation?

Nature Clinical Practice Urology volume 5, pages 190–191 (2008)Cite this article

Grober ED et al. (2007) Efficacy of changing testosterone gel preparations (Androgel or Testim) among suboptimally responsive hypogonadal men. Int J Impot Res [doi:10.1038/sj.ijir.3901618]

Background

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Bhasin S et al. (2006) Testosterone therapy in adult men with androgen deficiency syndromes: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 91: 1995–2010

    Article  CAS  Google Scholar 

  2. Harman SM et al. (2001) Longitudinal effects of aging on serum total and free testosterone levels in healthy men. Baltimore Longitudinal Study of Aging. J Clin Endocrinol Metab 86: 724–731

    Article  CAS  Google Scholar 

  3. Guay A and Jacobson J (2007) The relationship between testosterone levels, the metabolic syndrome (by two criteria), and insulin resistance in a population of men with organic erectile dysfunction. J Sex Med 4: 1046–1055

    Article  CAS  Google Scholar 

  4. Liverman CT and Blazer DG (2004) Testosterone and Aging: Clinical Research Directions. Washington, DC, USA: The National Academy Press

    Google Scholar 

  5. Marbury T et al. (2003) Evaluation of the pharmacokinetic profiles of the new testosterone topical gel formulation, Testim, compared to AndroGel. Biopharm Drug Dispos 24: 115–120

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Rachel Murphy, Associate Editor, Nature Clinical Practice.

Author information

Author notes

  1. David Geffen School of Medicine at UCLA, Division of Endocrinology, Harbor-UCLA Medical Center, 1000 W. Carson St Box 446, Torrance, CA 90502, USA swerdloff@labiomed.org

Authors and Affiliations

  1. and Chief of the Division of Endocrinology, RS Swerdloff is Professor of Medicine at the David Geffen School of Medicine at UCLA, Harbor-UCLA Medical Center, Torrance, CA, USA.,

    Ronald S Swerdloff

Authors
  1. Ronald S Swerdloff
    View author publications

    You can also search for this author in PubMed Google Scholar

Ethics declarations

Competing interests

Dr Swerdloff has declared associations with the following companies/organizations: Acrux (Consultant, Grant Recipient), Ardana (Consultant, Grant Recipient), Ascend Therapeutics (Consultant, Grant Recipient), Auxilium Pharmaceuticals (Consultant, Grant Recipient, Speaker), Bristol-Myers Squibb (Grant Recipient), Clarus Ventures (Consultant, Grant Recipient), Corcept Therapeutics (Consultant), GlaxoSmithKline (Consultant, Grant Recipient), Indevus Pharmaceuticals (Consultant, Grant Recipient), Eli Lilly (Grant Recipient), NIH (Grant and Contract Recipient), Organon International (Grant Recipient), Pierre Fabre (Consultant), Solvay Pharmaceuticals (Consultant, Grant Recipient, Speaker), and Repros Therapeutics (Consultant, Grant Recipient). Dr Swerdloff is not a stockholder or owner of any of these companies.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Swerdloff, R. Should hypogonadal men who are suboptimally responsive to testosterone gel switch to another gel preparation?. Nat Rev Urol 5, 190–191 (2008). https://doi.org/10.1038/ncpuro1057

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpuro1057

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing